Our venture capital fund focuses investments on early-stage life sciences companies looking to improve people’s outcomes with cancer.

PORTFOLIO HIGHLIGHTS

WUGEN Logo
White C4 Therapeutics logo
Arch Oncology Logo
NextRNA Logo
CareVet Logo
Geneoscopy logo
Mana Therapeutics logo